Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
Publication

GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells

Title
GC-MS-Based Endometabolome Analysis Differentiates Prostate Cancer from Normal Prostate Cells
Type
Article in International Scientific Journal
Year
2018
Authors
Lima, AR
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Araujo, AM
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Pinto, J
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Maria de Lourdes Bastos
(Author)
FFUP
View Personal Page You do not have permissions to view the institutional email. Search for Participant Publications View Authenticus page View ORCID page
Carvalho, M
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Title: MetabolitesImported from Authenticus Search for Journal Publications
Vol. 8
Final page: 23
ISSN: 2218-1989
Publisher: MDPI
Other information
Authenticus ID: P-00N-SXK
Abstract (EN): Prostate cancer (PCa) is an important health problem worldwide. Diagnosis and management of PCa is very complex because the detection of serum prostate specific antigen (PSA) has several drawbacks. Metabolomics brings promise for cancer biomarker discovery and for better understanding PCa biochemistry. In this study, a gas chromatography-mass spectrometry (GC-MS) based metabolomic profiling of PCa cell lines was performed. The cell lines include 22RV1 and LNCaP from PCa with androgen receptor (AR) expression, DU145 and PC3 (which lack AR expression), and one normal prostate cell line (PNT2). Regarding the metastatic potential, PC3 is from an adenocarcinoma grade IV with high metastatic potential, DU145 has a moderate metastatic potential, and LNCaP has a low metastatic potential. Using multivariate analysis, alterations in levels of several intracellular metabolites were detected, disclosing the capability of the endometabolome to discriminate all PCa cell lines from the normal prostate cell line. Discriminant metabolites included amino acids, fatty acids, steroids, and sugars. Six stood out for the separation of all the studied PCa cell lines from the normal prostate cell line: ethanolamine, lactic acid, beta-Alanine, L-valine, L-leucine, and L-tyrosine.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 15
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Discrimination between the human prostate normal and cancer cell exometabolome by GC-MS (2018)
Article in International Scientific Journal
Lima, AR; Araujo, AM; Pinto, J; Carmen Jeronimo; henrique, rmf; Maria de Lourdes Bastos; Carvalho, M; de Pinho, PG

Of the same journal

Toxicometabolomics: Small Molecules to Answer Big Toxicological Questions (2021)
Another Publication in an International Scientific Journal
Araujo, AM; Felix Carvalho; de Pinho, PG; Carvalho, M
Nonalcoholic Fatty Liver Disease and Endocrine Axes-A Scoping Review (2022)
Another Publication in an International Scientific Journal
Von-Hafe, M; Borges-Canha, M; Vale, C; Leite, AR; Neves, JS; Carvalho, Davide; Leite-Moreira AF
Metabolomics in the Identification of Biomarkers of Asthma (2021)
Another Publication in an International Scientific Journal
Villasenor, A; Eguiluz Gracia, I; Moreira, André; Wheelock, CE; Escribese, MM
Advances and Perspectives in Prostate Cancer Biomarker Discovery in the Last 5 Years through Tissue and Urine Metabolomics (2021)
Another Publication in an International Scientific Journal
Lima, AR; Pinto, J; Amaro, F; Maria de Lourdes Bastos; Carvalho, M; de Pinho, PG
Volatilomics Reveals Potential Biomarkers for Identification of Renal Cell Carcinoma: An In Vitro Approach (2020)
Article in International Scientific Journal
Amaro, F; Pinto, J; Rocha, S; Araujo, AM; Miranda Goncalves, V; Carmen Jeronimo; henrique, rmf; Maria de Lourdes Bastos; Carvalho, M; de Pinho, PG

See all (15)

Recommend this page Top
Copyright 1996-2025 © Instituto de Ciências Biomédicas Abel Salazar  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-06-28 at 19:09:08 | Acceptable Use Policy | Data Protection Policy | Complaint Portal